CD34 and neoplasm: Considering previously published data, we aim to perform a comparative evaluation of tumor and endothelial cell proliferation in PitNETs using double immunohistochemistry for CD34/MIB1 (CD34 to identify endothelial cells and MIB1 to highlight proliferative cells).